Early Adverse Events and Immune Response Following Second and Third COVID-19 Vaccination in Pregnancy

(1) Background: The adverse-effect profile and short-term obstetric and neonatal outcomes among pregnant women who were vaccinated with the BNT162b2 vaccine at any stage of pregnancy do not indicate any safety concerns. The vaccine is effective in generating a humoral immune response in pregnant wom...

Descripción completa

Detalles Bibliográficos
Autores principales: Toussia-Cohen, Shlomi, Yinon, Yoav, Peretz-Machluf, Ravit, Segal, Omri, Regev, Noam, Asraf, Keren, Doolman, Ram, Kubani, Yonatan, Gonen, Tal, Regev-Yochay, Gili, Bookstein Peretz, Shiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409660/
https://www.ncbi.nlm.nih.gov/pubmed/36012958
http://dx.doi.org/10.3390/jcm11164720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409660/
https://www.ncbi.nlm.nih.gov/pubmed/36012958
http://dx.doi.org/10.3390/jcm11164720

Ejemplares similares